Notices. Notice of application
297 words·~1 min read·
/register/2021/02/04/2021-02315·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4210-67-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-773] Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc. AGENCY: Drug Enforcement Administration, Justice. ACTION: Notice of application. SUMMARY: Mylan Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 8, 2021.
Such persons may also file a written request for a hearing on the application on or before March 8, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to:
(1)Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and
(2)Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on December 18, 2020, Mylan Pharmaceuticals Inc., 2898 Manufacturers Road, Greensboro, North Carolina 27406-4600, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Drug code Schedule Remifentanil 9739 II The company plans to import the above-controlled substance as the Federal Drug Administration-approved drug product in finished dosage form for commercial distribution to its customers. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). William T. McDermott, Assistant Administrator. [FR Doc. 2021-02315 Filed 2-3-21; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources